X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (610) 610
Publication (117) 117
Book Review (23) 23
Book Chapter (10) 10
Newspaper Article (10) 10
Conference Proceeding (5) 5
Book / eBook (2) 2
Dissertation (2) 2
Patent (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (231) 231
humans (220) 220
alzheimer's disease (187) 187
aged (156) 156
male (155) 155
female (152) 152
clinical neurology (138) 138
dementia (137) 137
neurology (136) 136
aged, 80 and over (131) 131
neurosciences (111) 111
article (101) 101
pathology (71) 71
middle aged (67) 67
mild cognitive impairment (64) 64
brain (60) 60
alzheimer’s disease (55) 55
diagnosis (55) 55
alzheimers-disease (53) 53
parkinson's disease (47) 47
alzheimer disease - pathology (45) 45
neuropsychological tests (43) 43
brain - pathology (42) 42
medical research (41) 41
alzheimers disease (40) 40
biomarkers (37) 37
clinical trials (34) 34
alzheimer disease - diagnosis (33) 33
alzheimer disease - drug therapy (33) 33
alzheimer disease - metabolism (33) 33
mental disorders (32) 32
neurodegenerative diseases (30) 30
cognitive ability (29) 29
neuropathology (29) 29
geriatrics & gerontology (28) 28
autopsy (26) 26
dementia disorders (26) 26
magnetic resonance imaging (26) 26
research (26) 26
risk factors (26) 26
aging (25) 25
alzheimer disease - physiopathology (25) 25
analysis (25) 25
brain - metabolism (25) 25
longitudinal studies (25) 25
risk (25) 25
alzheimer disease - psychology (24) 24
multidisciplinary sciences (24) 24
abridged index medicus (23) 23
alzheimer disease - genetics (23) 23
lewy bodies (23) 23
medicine, experimental (23) 23
amyloid beta-peptides - metabolism (21) 21
medicine & public health (21) 21
neuroimaging (21) 21
alzheimer disease - diagnostic imaging (20) 20
amyloid (20) 20
disease (20) 20
internal medicine (20) 20
memory (20) 20
parkinson disease - complications (20) 20
parkinson disease - pathology (20) 20
age (19) 19
alzheimer disease - blood (19) 19
alzheimer disease (18) 18
disease progression (18) 18
positron-emission tomography (18) 18
research article (18) 18
alzheimer disease - complications (17) 17
animals (17) 17
apolipoprotein-e (17) 17
cholesterol (17) 17
cognitive impairment (17) 17
parkinsons-disease (17) 17
amyloid precursor protein (16) 16
biomarker (16) 16
brain - diagnostic imaging (16) 16
cognition (16) 16
cohort studies (16) 16
double-blind method (16) 16
proteins (16) 16
sensitivity and specificity (16) 16
a-beta (15) 15
alpha-synuclein (15) 15
drug therapy (15) 15
expression (15) 15
geriatrics (15) 15
parkinson’s disease (15) 15
pharmacology & pharmacy (15) 15
physiological aspects (15) 15
prevalence (15) 15
psychiatry (15) 15
severity of illness index (15) 15
adult (14) 14
apolipoproteins (14) 14
brain - physiopathology (14) 14
health aspects (14) 14
immunohistochemistry (14) 14
medical imaging (14) 14
medicine (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurobiology of Aging, ISSN 0197-4580, 2014, Volume 35, Issue 3, pp. 720 - 720
Journal Article
Lancet Neurology, ISSN 1474-4422, 2012, Volume 11, Issue 3, pp. 241 - 249
Journal Article
Current Alzheimer research, 2017, Volume 14, Issue 4, pp. 354 - 355
Journal Article
Current Alzheimer Research, ISSN 1567-2050, 04/2017, Volume 14, Issue 4, pp. 412 - 425
Journal Article
International Journal of Alzheimer's Disease, ISSN 2090-8024, 2012, Volume 2012, pp. 728983 - 8
Acetylcholinesterase (AChE) remains a highly viable target for the symptomatic improvement in Alzheimer's disease (AD) because cholinergic deficit is a... 
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 10/2015, Volume 24, Issue 10, pp. 1355 - 1360
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 06/2017, Volume 26, Issue 6, pp. 735 - 739
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 4, pp. 322 - 333
In two phase 3 trials in patients with Alzheimer's disease, bapineuzumab, a humanized anti–amyloid-beta monoclonal antibody, did not improve clinical outcomes.... 
ANTIBODIES | MEDICINE, GENERAL & INTERNAL | EPITOPE | IMAGING ABNORMALITIES | PEPTIDE | MOUSE MODEL | Phosphorylation | Humans | Middle Aged | Male | Positron-Emission Tomography | Treatment Failure | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Biomarkers - analysis | Alzheimer Disease - drug therapy | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Cognition - drug effects | Neuropsychological Tests | Amyloid beta-Peptides - antagonists & inhibitors | Apolipoproteins E - genetics | Intention to Treat Analysis | Amyloid beta-Peptides - analysis | Brain - pathology | Aged | Biomarkers - cerebrospinal fluid | Edema - chemically induced | Alzheimer Disease - genetics | Monoclonal antibodies | Product development | Research | Drug therapy | Alzheimer's disease | Health aspects | Edema | Nuclear magnetic resonance--NMR | Intravenous administration | Neurodegenerative diseases | Cognitive ability | Clinical trials | Cerebrospinal fluid | Apolipoproteins | Patients | Studies | Tau protein | Apolipoprotein E | Immunotherapy | Alleles | Dementia disorders | Alzheimers disease | Index Medicus | Abridged Index Medicus | Brain | Neurosciences | pathology | Biological Markers | Antibodies | Cognition | tau Proteins | 80 and over | genetics | Amyloid beta-Peptides | Apolipoproteins E | Monoclonal | Neurovetenskaper | drug therapy | chemically induced | Humanized | drug effects | Alzheimer Disease | analysis | antagonists & inhibitors | cerebrospinal fluid | adverse effects | therapeutic use
Journal Article